Consolidated Balance Sheets (Current Period Unaudited) - USD ($) $ in Thousands	Sep. 30, 2025	Dec. 31, 2024
ASSETS
Cash and cash equivalents	$ 10,305	$ 12,145
Restricted cash	10,551	8,264
Investments
Fixed income securities, held-to-maturity	0	1,000
Investments in related parties	22,764	10,073
Accounts receivable	1,169	263
Interest and dividend receivables	0	19
Prepaid expenses	295	288
Property, plant and equipment, net	44	62
Lease assets	616	611
Goodwill	6,492	6,492
Intangible assets, net	137	193
Other assets	626	575
Total assets	55,009	42,168
LIABILITIES
Accounts payable	49	106
Accrued salaries, wages and benefits	493	496
Escrow liabilities	10,396	8,110
Other accrued expenses	429	360
Reserve for title claims	682	637
Lease liabilities	618	616
Other liabilities	18	35
Total liabilities	12,685	10,360
Commitments and contingencies (refer to Note 12)
STOCKHOLDERS’ EQUITY
Common stock, $0.02 par value, 7,000,000 shares authorized as of September 30, 2025 and 35,000,000 shares authorized as of December 31, 2024; 5,204,713 shares issued and outstanding as of September 30, 2025 and 2,813,214 shares issued and outstanding as of December 31, 2024	100	52
Additional paid-in capital	39,058	30,491
Retained earnings	3,267	1,413
Total stockholders’ equity	42,425	31,956
Noncontrolling interests	(101)	(148)
Total equity	42,324	31,808
Total liabilities and stockholders’ equity	55,009	42,168
Equity Method Investment, Nonconsolidated Investee or Group of Investees [Member]
Investments
Investments in limited partnerships	$ 2,010	$ 2,183